K-STREET TRACKER
FOLLOW THE MONEY INTO THE SWAMP
Every federal lobbying filing tagged with a public-company ticker — who is spending, which firms they hire, and which members trade right around the filing.
Filings tracked
19,882
thru 2026-05-08
Total reported $
$2.7B
disclosed lobbying
Distinct clients
2,220
paying companies
Tickers targeted
1,207
public companies
💸 Top Spending Clients
| # | Client | Filings | Total $ |
|---|---|---|---|
| 1 |  PFIZER INC.PFE | 47 | $46.8M |
| 2 |  GENERAL MOTORS COMPANYGM | 61 | $46.8M |
| 3 |  META PLATFORMS INC. AND VARIOUS SUBSIDIARIESMETA | 12 | $44.9M |
| 4 | VISA INC.V | 45 | $37.7M |
| 5 |  AMAZON.COM SERVICES LLCAMZN | 36 | $32.8M |
| 6 |  LOCKHEED MARTIN CORPORATIONLMT | 73 | $29.0M |
| 7 |  FEDEX CORPORATIONFDX | 69 | $27.8M |
| 8 |  ELI LILLY AND COMPANYLLY | 56 | $27.1M |
| 9 |  ALTRIA CLIENT SERVICES LLCMO | 142 | $25.2M |
| 10 |  AMGEN INCAMGN | 19 | $24.9M |
| 11 |  COMCAST CORPORATIONCMCSV | 179 | $24.7M |
| 12 |  MERCK & CO INCMRK | 14 | $24.0M |
| 13 |  SOUTHERN COMPANYSO | 53 | $23.9M |
| 14 |  GOOGLE CLIENT SERVICES LLCGOOGL | 79 | $22.6M |
| 15 |  APPLE INCAAPL | 9 | $22.1M |
| 16 |  T-MOBILE USA INC.TMUS | 121 | $21.0M |
| 17 |  UNITEDHEALTH GROUP INCUNH | 19 | $20.4M |
| 18 |  VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIESVZ | 40 | $20.1M |
| 19 |  OCCIDENTAL PETROLEUM CORPORATIONOXY | 30 | $19.7M |
| 20 |  MICROSOFT CORPORATIONMSFT | 103 | $18.8M |
| 21 |  QUALCOMM INCORPORATEDQCOM | 40 | $17.2M |
| 22 |  GENERAL DYNAMICS CORPGD | 11 | $17.0M |
| 23 |  BOEING COMPANYBA | 23 | $16.9M |
| 24 | THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)CI | 13 | $16.9M |
| 25 |  ORACLE CORPORATIONORCL | 58 | $16.7M |
🎯 Top Lobbied Tickers
| # | Ticker | Filings | Total $ |
|---|---|---|---|
| 1 | META Meta Platforms Inc. | 129 | $50.2M |
| 2 | PFE Pfizer Inc. | 87 | $48.6M |
| 3 | GM General Motors Company | 103 | $48.4M |
| 4 | V Visa Inc. | 46 | $37.7M |
| 5 | AMZN Amazon.com Inc. | 80 | $35.3M |
| 6 | LMT Lockheed Martin Corporation | 88 | $29.4M |
| 7 | FDX FedEx Corporation | 82 | $28.3M |
| 8 | LLY Eli Lilly and Company | 83 | $28.1M |
| 9 | AMGN Amgen Inc. | 95 | $28.0M |
| 10 | MRK Merck & Co. Inc. | 92 | $27.5M |
| 11 | AAPL Apple Inc. | 64 | $26.8M |
| 12 | GOOGL Alphabet Inc. Class A | 123 | $26.6M |
| 13 | MO | 164 | $26.2M |
| 14 | SO Southern Company | 108 | $26.1M |
| 15 | UNH UnitedHealth Group Inc. | 67 | $23.9M |
| 16 | VZ Verizon Communications Inc. | 116 | $23.8M |
| 17 | TMUS | 159 | $22.7M |
| 18 |  CHTR | 137 | $22.6M |
| 19 | GD General Dynamics Corporation | 127 | $22.5M |
| 20 |  TAT&T Inc. | 134 | $21.6M |
| 21 | ORCL Oracle Corporation | 132 | $20.6M |
| 22 | CMCSA Comcast Corporation | 141 | $20.4M |
| 23 | CI The Cigna Group | 64 | $19.9M |
| 24 | OXY Occidental Petroleum Corporation | 36 | $19.9M |
| 25 | MSFT Microsoft Corporation | 122 | $19.2M |
🆕 Filtered Filings · DAVITA INC
clear filters| Date | Ticker | Client | Registrant | Amount | Issue |
|---|---|---|---|---|---|
| 2026-04-21 | DVA | DAVITA INC | CAPITOL HILL CONSULTING GROUP | $60K | Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Medicare reimbursement and Medicare Secondary Payer policies, including H.R. 2199 and S.1173. |
| 2026-04-20 | DVA | DAVITA INC | DAVITA INC. | $1.2M | H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act Exclusion of skin substitute spend from PY 2025 CKCC Kidney Contracting Entities (KCE) benchmarks Issues related to billing for skin substitute products in value-based care models Issues related to hospice and concurrent dialysis H.R. 6214/S. 2730, Kidney Care Access Protection Act Issues related to End Stage Renal Disease (ESRD) Perspective Payment System (PPS) Issues related to nursing shortages CMS regulations pertaining to the Medicare Advantage Program Issues related to home dialysis Issues related to chronic kidney disease (CKD) and prevention Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidney Care Choices (KCC) Model and the Comprehensive Kidney Care Contracting (CKCC) voluntary payment options H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act Exclusion of skin substitute spend from PY 2025 CKCC Kidney Contracting Entitie |
| 2026-04-10 | DVA | DAVITA INC | APOLLO GOVERNMENT RELATIONS | $20K | HR 2199/S 1173, Restore Protections for Dialysis Patients Act Issues related to access to treatment for End Stage Renal Disease (ESRD) HR 2199/S 1173, the Restore Protections for Dialysis Patients Act Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD) |
| 2026-01-20 | DVA | DAVITA INC | DAVITA INC. | $1.1M | H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act Issues related to billing for skin substitute products in value-based care models Issues related to hospice and concurrent dialysis H.R. 6214/S. 2730, Kidney Care Access Protection Act Issues related to End Stage Renal Disease (ESRD) Perspective Payment System (PPS) Issues related to nursing shortages CMS regulations pertaining to the Medicare Advantage Program Issues related to home dialysis Issues related to chronic kidney disease (CKD) and prevention Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidney Care Choices (KCC) Model and the Comprehensive Kidney Care Contracting (CKCC) voluntary payment options H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act Issues related to billing for skin substitute products in value-based care models Issues related to hospice and concurrent dialysis H.R. 6214/S. 2730, Kidney Care Access Protect |
| 2026-01-20 | DVA | DAVITA INC | DAVITA INC. | $1.1M | H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act Issues related to End Stage Renal Disease (ESRD) Perspective Payment System (PPS) Issues related to nursing shortages CMS regulations pertaining to the Medicare Advantage Program Issues related to home dialysis Issues related to chronic kidney disease (CKD) and prevention Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidney Care Choices (KCC) Model and the Comprehensive Kidney Care Contracting (CKCC) voluntary payment options ESRD facilities serving as originating sites for telehealth services under the Medicare program H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act Issues related to End Stage Renal Disease (ESRD) Perspective Payment System (PPS) Issues related to nursing shortages CMS regulations pertaining to the Medicare Advantage Program Issues related to home dialysis Issues related to chronic kidney disease (CKD) and prev |
| 2026-01-20 | DVA | DAVITA INC | CAPITOL HILL CONSULTING GROUP | $60K | Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Medicare reimbursement and Medicare Secondary Payer policies, including H.R. 2199 and S.1173. |
| 2026-01-15 | DVA | DAVITA INC | APOLLO GOVERNMENT RELATIONS | $20K | HR 2199/S 1173, Restore Protections for Dialysis Patients Act Issues related to access to treatment for End Stage Renal Disease (ESRD) HR 2199/S 1173, the Restore Protections for Dialysis Patients Act Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD) |
| 2025-10-20 | DVA | DAVITA INC | DAVITA INC. | $1.0M | H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act Issues related to End Stage Renal Disease (ESRD) Perspective Payment System (PPS) Issues related to nursing shortages CMS regulations pertaining to the Medicare Advantage Program Issues related to home dialysis Issues related to chronic kidney disease (CKD) and prevention Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidney Care Choices (KCC) Model and the Comprehensive Kidney Care Contracting (CKCC) voluntary payment options H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act Issues related to End Stage Renal Disease (ESRD) Perspective Payment System (PPS) Issues related to nursing shortages CMS regulations pertaining to the Medicare Advantage Program Issues related to home dialysis Issues related to chronic kidney disease (CKD) and prevention Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choic |
| 2025-10-19 | DVA | DAVITA INC | CAPITOL HILL CONSULTING GROUP | $60K | Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Medicare reimbursement and Medicare Secondary Payer policies, including H.R. 2199 and S.1173. |
| 2025-10-06 | DVA | DAVITA INC | APOLLO GOVERNMENT RELATIONS | $20K | HR 2199, Restore Protections for Dialysis Patients Act Issues related to access to treatment for End Stage Renal Disease (ESRD) HR 2199, the Restore Protections for Dialysis Patients Act Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD) |
| 2025-07-21 | DVA | DAVITA INC | DAVITA INC. | $1.1M | H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act Issues related to End Stage Renal Disease (ESRD) Perspective Payment System (PPS) Issues related to nursing shortages CMS regulations pertaining to the Medicare Advantage Program Issues related to home dialysis Issues related to chronic kidney disease (CKD) and prevention Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidney Care Choices (KCC) Model and the Comprehensive Kidney Care Contracting (CKCC) voluntary payment options ESRD facilities serving as originating sites for telehealth services under the Medicare program H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act Issues related to End Stage Renal Disease (ESRD) Perspective Payment System (PPS) Issues related to nursing shortages CMS regulations pertaining to the Medicare Advantage Program Issues related to home dialysis Issues related to chronic kidney disease (CKD) and prev |
| 2025-07-21 | DVA | DAVITA INC | CAPITOL HILL CONSULTING GROUP | $60K | Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Medicare reimbursement and Medicare Secondary Payer policies, including H.R. 2199 and S.1173. |
| 2025-07-12 | DVA | DAVITA INC | APOLLO GOVERNMENT RELATIONS | $20K | HR 2199, Restore Protections for Dialysis Patients Act Issues related to access to treatment for End Stage Renal Disease (ESRD) HR 2199, the Restore Protections for Dialysis Patients Act Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD) |
| 2025-04-21 | DVA | DAVITA INC | DAVITA INC. | $1.1M | Issues related to Veterans Affairs and dialysis Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, provisions related to dialysis (no bill number) H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act Issues related to End Stage Renal Disease (ESRD) Perspective Payment System (PPS) Issues related to nursing shortages CMS regulations pertaining to the Medicare Advantage Program Issues related to home dialysis Issues related to chronic kidney disease (CKD) and prevention Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidney Care Choices (KCC) Model and the Comprehensive Kidney Care Contracting (CKCC) voluntary payment options ESRD facilities serving as originating sites for telehealth services under the Medicare program H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act Issues related to End Stage Renal Disease (ESRD) Perspective Payment System (PPS |
| 2025-04-21 | DVA | DAVITA INC | CAPITOL HILL CONSULTING GROUP | $60K | Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Medicare reimbursement and Medicare Secondary Payer policies, including H.R. 2199 and S.1173. |
| 2025-04-21 | DVA | DAVITA INC | AVOQ, LLC | $20K | Issues related to Medicare payment for End Stage Renal Disease (ESRD) Issues related to health care workforce shortage |
| 2025-04-14 | DVA | DAVITA INC | APOLLO GOVERNMENT RELATIONS | $20K | HR 2199, Restore Protections for Dialysis Patients Act Issues related to access to treatment for End Stage Renal Disease (ESRD) HR 2199, the Restore Protections for Dialysis Patients Act Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD) |
| 2025-01-21 | DVA | DAVITA INC | DAVITA INC. | $1.1M | H.R. 6860/S. 5018, Restore Protections for Dialysis Patients Act Issues related to End Stage Renal Disease (ESRD) Perspective Payment System (PPS) Issues related to nursing shortages CMS regulations pertaining to the Medicare Advantage program Issues related to home dialysis Issues related to chronic kidney disease (CKD) and prevention Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidney Care Choices (KCC) Model and the Comprehensive Kidney Care Contracting (CKCC) voluntary payment options ESRD facilities serving as originating sites for telehealth services under the Medicare program H.R. 5074/S. 4510, the Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments (PATIENT) Act H.R. 5027/S. 4469, Chronic Kidney Disease Improvement in Research and Treatment Act H.R. 6860/S. 5018, Restore Protections for Dialysis Patients Act Issues related to End Stage Renal Disease (ESRD) Perspect |
| 2025-01-21 | DVA | DAVITA INC | AVOQ, LLC | $50K | Issues related to Medicare payment for End Stage Renal Disease (ESRD); Issues related to H.R.6860, Restore Protections for Dialysis Patients Act Issues related to health care workforce shortage, including OMB's ESRD Prospective Payment System proposed rule |
| 2025-01-20 | DVA | DAVITA INC | CAPITOL HILL CONSULTING GROUP | $60K | Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Medicare reimbursement and Medicare Secondary Payer policies, including H.R. 6860. Issues surrounding Medicare reimbursement of oral ESRD drugs. |